Case Reports
doi: 10.1007/BF00210616.
Definitive assignment of the growth hormone-releasing factor gene to 20q11.2
Affiliations
- PMID: 8112752
- DOI: 10.1007/BF00210616
Item in Clipboard
Case Reports
Definitive assignment of the growth hormone-releasing factor gene to 20q11.2
Hum Genet.
1994 Feb.
Abstract
The growth hormone-releasing factor (GHRF) gene has been mapped by different authors alternatively at 20p12 and 20q11.2. In situ hybridization of the relevant probe to metaphases of two patients with different translocations involving 20q has allowed us to map it definitively at 20q11.2.
Similar articles
-
The gene for human growth hormone-releasing factor (GHRF) maps to or near chromosome 20p12.Cytogenet Cell Genet. 1991;57(1):39-40. doi: 10.1159/000133110. Cytogenet Cell Genet. 1991. PMID: 1855391
-
Genetic mapping of the human growth hormone-releasing factor gene (GHRF) using two intragenic polymorphisms detected by PCR amplification.Genomics. 1994 Mar 1;20(1):132-4. doi: 10.1006/geno.1994.1140. Genomics. 1994. PMID: 8020943
-
Physical localization of chromosome 20 markers using somatic cell hybrid cell lines and fluorescence in situ hybridization.Genomics. 1992 Oct;14(2):532-5. doi: 10.1016/s0888-7543(05)80262-9. Genomics. 1992. PMID: 1427875
-
[Clinical and cytogenetic study of 6 cases of hematological disorders associated with 20q- and t (20;21) (q11;q11) abnormalities].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):138-42. doi: 10.3760/cma.j.issn.1003-9406.2013.04.003. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013. PMID: 23568721 Chinese.
-
Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2.Br J Haematol. 2006 Nov;135(4):492-9. doi: 10.1111/j.1365-2141.2006.06328.x. Epub 2006 Sep 26. Br J Haematol. 2006. PMID: 16999846
Cited by
-
GHRH and the prostate.Rev Endocr Metab Disord. 2025 Jun;26(3):467-481. doi: 10.1007/s11154-024-09922-9. Epub 2024 Nov 7. Rev Endocr Metab Disord. 2025. PMID: 39505776 Review.